LCTX

LCTX Common Stock

$535.72MQuarterly · USD

Period ending:

LCTX FY Common StockUSD
LCTX FY Common Stock1992-06-30: $0.001993-06-30: $0.001994-06-30: $0.001995-06-30: $0.001996-06-30: $0.001998-06-30: $0.001998-12-31: $0.001999-12-31: $27.20M2000-12-31: $28.36M2001-12-31: $30.60M2002-12-31: $32.37M2003-12-31: $32.86M2004-12-31: $38.72M2005-12-31: $40.25M2006-12-31: $0.002007-12-31: $40.70M2008-12-31: $43.18M2009-12-31: $59.72M2010-12-31: $101.14M2011-12-31: $115.14M2012-12-31: $119.82M2013-12-31: $203.46M2014-12-31: $234.84M2015-12-31: $274.34M2016-12-31: $317.88M2017-12-31: $378.49M2018-12-31: $354.27M2019-12-31: $387.06M2020-12-31: $393.94M2021-12-31: $434.53M2022-12-31: $440.28M2023-12-31: $451.34M2024-12-31: $484.72M2025-12-31: $515.47M$515.47M$0.00
1992-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LCTX common stock history

Par value of issued common shares. The available annual fiscal periods series contains 34 observations from Jun 30, 1992 to Dec 31, 2025.

Lineage Cell Therapeutics, Inc. Common Stock Common Stock — Annual fiscal periods (USD)
Period endingCommon Stock (USD)
515,467,000
484,722,000
451,343,000
440,280,000
434,529,000
393,944,000
387,062,000
354,270,000
378,487,000
317,878,000
274,342,000
234,842,998
203,456,401
119,821,243
115,144,787
101,135,428
59,722,318
43,184,606
40,704,136
0
40,251,097
38,718,197
32,857,552
32,374,883
30,602,003
28,360,007
27,200,380
0
0
0
0
0
0
0

Compare common stock

All LCTX financial metrics · LCTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.